Bifunctional Peptide Amphiphile Hydrogel Orchestrates Concerted Antioxidant and Anti‐Inflammatory Actions to Counter Myocardial Ischemia/Reperfusion Injury
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.71082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yuanyuan Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Department of Cardiology and Laboratory of Heart C…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Antioxidants, Anti-Inflammatory Agents, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development projects in Hainan Province, Guandong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Myocardial ischaemia/reperfusion injury presents significant clinical challenges driven by a self‐perpetuating cycle of oxidative stress and inflammation. Current therapeutic strategies fail to simultaneously address these interconnected pathological events. Here, we present T&A‐Gel, a supramolecular peptide amphiphile hydrogel integrating α‐tocopherol and Angiotensin‐(1‐7) (Ang‐(1‐7)) through covalent conjugation to enable localized co‐delivery and synergistically disrupt this oxidative‐inflammatory feed‐forward circuit. Upon hierarchical self‐assembly into filamentous nanofibres, T&A‐Gel forms a sustained‐release depot that exposes Ang‐(1‐7) moieties while sequestering hydrophobic α‐tocopherol. This design enables α‐tocopherol to scavenge excess reactive oxygen species, ameliorating oxidative mitochondrial dysfunction and reducing cardiomyocyte apoptosis, while exposed Ang‐(1‐7) acts as a selective Mas receptor (MasR) agonist, activating the protective MasR/PI3K/Akt signaling axis. This dual‐action mechanism suppresses NF‐κB nuclear translocation and inhibits pro‐inflammatory cytokine cascades. In vitro, T&A‐Gel significantly enhanced hypoxia/reoxygenation‐injured cardiomyocyte viability. In vivo, T&A‐Gel demonstrated prolonged retention with substantial reduction in infarct size and cardiac necrosis biomarkers. Quantitative analysis confirmed substantial attenuation of interstitial fibrosis and cardiomyocyte hypertrophy, translating into restored ejection fraction and reduced ventricular dilation with excellent biocompatibility. These findings establish injectable supramolecular hydrogels as a powerful strategy for disrupting the interconnected injury cascade via mechanistically complementary payloads, offering a paradigm for precision cardioprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, P. R…
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, P. R. China.
- State Key Laboratory of Optoelectronic Materials and Technologies, Guangdong Province Key Laboratory of Display Material and Technology, School of Electronics and Information Technology, Sun Yat-sen University, Guangzho…
- Nankai International Advanced Research Institute, Nankai University (Shenzhen Futian), Shenzhen, Guangdong, P. R. China.
- Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Nanfang Hospital, Southern Medical University, Guangzhou, P. R. China.
- Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical University, Guangzh…
ORCID-Profile: Zhimou Yang, Jie Zhan, Yanbin Cai
Förderung
- National Natural Science Foundation of China
- Key Research and Development projects in Hainan Province
- Guandong Basic and Applied Basic Research Foundation
- Nanfang Hospital, Southern Medical University
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research Foundation
- Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wu, Y., Luo, S., Xu, G., Liao, X., Chen, H., Wu, Y., Wu, Z., Xie, X., Yang, Z., Zhan, J., & Cai, Y. (2026). Bifunctional Peptide Amphiphile Hydrogel Orchestrates Concerted Antioxidant and Anti‐Inflammatory Actions to Counter Myocardial Ischemia/Reperfusion Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71082
Vancouver
Wu Y, Luo S, Xu G, Liao X, Chen H, Wu Y, et al. Bifunctional Peptide Amphiphile Hydrogel Orchestrates Concerted Antioxidant and Anti‐Inflammatory Actions to Counter Myocardial Ischemia/Reperfusion Injury. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71082
BibTeX
@article{Wu2026,
author = {Wu, Yuanyuan and Luo, Siman and Xu, Guanghui and Liao, Xu and Chen, Huiming and Wu, Yajie and Wu, Zhiye and Xie, Xi and Yang, Zhimou and Zhan, Jie and Cai, Yanbin},
title = {Bifunctional Peptide Amphiphile Hydrogel Orchestrates Concerted Antioxidant and Anti‐Inflammatory Actions to Counter Myocardial Ischemia/Reperfusion Injury},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71082}
}
EUVIMED